Aytu Biopharma Inc
NASDAQ:AYTU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aytu Biopharma Inc
NASDAQ:AYTU
|
US |
|
T
|
Tencent Holdings Ltd
DUS:NNND
|
CN |
|
Aptiv PLC
NYSE:APTV
|
IE |
|
Citigroup Inc
NYSE:C
|
US |
|
A
|
ASML Holding NV
DUS:ASME
|
NL |
|
E
|
Experian PLC
F:J2B
|
IE |
|
PhosAgro PAO
MOEX:PHOR
|
RU |
|
Laekna Inc
F:4U4
|
CN |
|
3
|
3M Co
SIX:MMM
|
US |
|
P
|
Procter & Gamble Co
SWB:PRG
|
US |
|
Caterpillar Inc
NYSE:CAT
|
US |
|
A
|
Accenture PLC
SWB:CSA
|
IE |
|
N
|
Neste Oyj
XBER:NEF
|
FI |
|
M
|
Mondelez International Inc
XMUN:KTF
|
US |
|
U
|
UPM-Kymmene Oyj
LSE:0NV5
|
FI |
Bankruptcy Probability
Aytu Biopharma Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Aytu Biopharma Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Aytu Biopharma Inc
NASDAQ:AYTU
|
25m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
618.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
317B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
237.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
184.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
250.7B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Aytu Biopharma Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Aytu Biopharma Inc has total debt of 20m USD. This includes both short-term (10.4m USD) and long-term (9.5m USD) debt.
You can find a full breakdown on its Balance Sheet.
